Caroline Hansi
About Caroline Hansi
Caroline Hansi is a Territory Manager in Immuno-Oncology at Bristol-Myers Squibb with over a decade of experience in the pharmaceutical industry, including roles in product and brand account management.
Company
Caroline Hansi is currently employed at Bristol-Myers Squibb, where she holds the position of Territory Manager Immuno-Onkologie. Her role includes managing and overseeing the distribution and promotion of immuno-oncology treatments within her assigned territory.
Title
As Territory Manager Immuno-Onkologie, Caroline Hansi is responsible for the strategic implementation of sales initiatives and engagement with healthcare professionals. This position leverages her deep knowledge of immuno-oncology and her ability to manage territory-specific challenges and opportunities.
Education and Expertise
Caroline Hansi pursued her higher education at the University of Erlangen-Nuremberg from 2003 to 2007. Prior to this, she studied at TU Bergakademie Freiberg from 2001 to 2003. The combination of these academic experiences has provided her with a strong foundation in pharmaceutical sciences, essential for her roles in product and brand management within the industry.
Professional Background
Caroline Hansi began her career at Janssen Inc. with a marketing traineeship in 2008, followed by a role in professional education in 2007. Over the years, she has held various positions in product management at UCB and Recordati, enhancing her expertise in pharmaceutical product management. Her tenure at AbbVie from 2014 to 2018, first as a Product Manager and later as Brand Account Manager Specialty Care, provided her with significant experience in managing specialty care products.
Career Achievements
Caroline Hansi boasts over a decade of experience in the pharmaceutical industry. Notable phases of her career include her contributions at AbbVie, where she was responsible for brand account management in specialty care, and at Bristol-Myers Squibb, where she has been serving as Territory Manager Immuno-Onkologie since March 2018. Her roles across these companies have equipped her with substantial knowledge and expertise in product and territory management within the pharmaceutical sector.